Kazia Therapeutics Limited - ADR
KZIA
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.5M
Close$
$2.54
73.5% downside
Current Fair Value
73.5% downsideOvervalued by 73.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $15.50 Million |
|---|---|
| Enterprise Value | $-53,790,964.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-18.9 |
| Beta | 2.15 |
| Outstanding Shares | 3,120,426 |
Return
| Return on Equity | -97.92% |
|---|---|
| Return on Assets | -63.98% |
| Return on Invested Capital | -90.83% |
Valuation & Multiples
| P/E Ratio | -1.32 |
|---|---|
| PEG | -0.97 |
| Price to Sales | - |
| Price to Book Ratio | 0.68 |
| Enterprise Value to Revenue | -21.41 |
| Enterprise Value to EBIT | 1.27 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 4, 2026
EPS Estimate
$-0.61
Average shareholder expectationRevenue Estimate
$488,858
Average shareholder expectationNext Earnings Call
Expected Date
March 2, 2027
EPS Estimate
$-0.45
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0837▲ 8.37% |
|---|---|
| Total Calls | 365,700▲ Infinity% |
| Total Puts | 30,600▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 116.63%▲ 60.42% |
|---|---|
| Total Invested | $50.73M▲ 288.78% |
| Investors Holding | 41▲ 18.00% |
ESG Score
No data